Dr. Eric M. Ketcham, MD

Dr. Ketcham practices at Cenikor Farmington in Farmington, New Mexico.

Dr. Ketcham's NPI, 1134193352, was assigned on February 14, 2006. Dr. Ketcham holds New Mexico license MD2004-0044.

Dr. Ketcham's primary practice is Cenikor Farmington, at 1313 Mission Avenue, Farmington, NM 87401. The practice phone is (505) 327-7218.

Dr. Ketcham's primary practice is Cenikor Farmington in Farmington, New Mexico. Dr. Ketcham is also affiliated with San Juan Regional Medical Center. The medical group on file is San Juan Health Partners Physiatry. Dmand AI also links Dr. Ketcham to 2 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account. Dr. Ketcham's employer is on file too: a behavioral health center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ketcham practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Ketcham's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Ketcham is licensed in New Mexico.

CMS data shows 95 Medicare services from Dr. Ketcham across 4 procedure codes in 2024, for 84 Medicare patients. Medicare paid $11,447 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 84 Medicare patients who saw Dr. Ketcham in 2024. The largest group is 65 to 74, with 30 patients. 64% of them have high blood pressure, and 62% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ketcham's median patient age at 38, with 43% women.

In 2024, Dr. Ketcham wrote 476 Medicare Part D claims for 74 patients. 99% of them were for generic drugs. CMS names the drug for 314 of them, across 11 drugs with 11 or more claims each, at $14,283 in total drug cost. In 2023, CMS named 218 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Ketcham for performance year 2024, reported as part of a group. Dr. Ketcham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ketcham as offering telehealth.

Dmand AI links 7 papers to Dr. Ketcham, published from 2018 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Emergency Service, Hospital, Opioid-Related Disorders and Analgesics, Opioid. Dr. Ketcham has published most often in Ann Emerg Med. Dr. Ketcham's most frequent co-authors are Alexis Marie Lapietra, DO, Lewis Nelson, MD and Reuben Jesse Strayer, MD.

Dmand AI links Dr. Ketcham to 1 clinical trial. Conditions studied include Opioid-Related Disorders and Narcotic-Related Disorders.

CMS Open Payments shows 8 general payments to Dr. Ketcham from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Alkermes, Inc. paid the most, $142.